[{"Assets_0_FY_USD":10425700000.0,"CommonStockDividendsPerShareDeclared_4_FY_USD":0.96,"EarningsPerShareBasic_4_FY_USD":-0.52,"EarningsPerShareDiluted_4_FY_USD":-0.52,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":156300000.0,"NetIncomeLoss_4_FY_USD":-68900000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_4_FY_USD":4138700000.0,"StockholdersEquity_0_FY_USD":5151700000.0,"StockholdersEquityConverted_0_FY_USD":5151700000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":133600000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":133600000.0,"Ticker":"PRGO","CIK":"1585364","name":"PERRIGO CO PLC","OfficialName":"Perrigo Company plc Ordinary Shares","form":"10-K","period":"20211231","fy":"2021.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4754722726.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20220301"}]